Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158


The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.

Slotta-Huspenina J, Koch I, de Leval L, Keller G, Klier M, Bink K, Kremer M, Raffeld M, Fend F, Quintanilla-Martinez L.

Haematologica. 2012 Sep;97(9):1422-30. doi: 10.3324/haematol.2011.055715. Epub 2012 Feb 7.


Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.

Sander B, Flygare J, Porwit-Macdonald A, Smith CI, Emanuelsson E, Kimby E, Liden J, Christensson B.

Int J Cancer. 2005 Nov 10;117(3):418-30.


Cyclin D1 positive multiple myeloma: predominance of the short, 3'UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions.

Slotta-Huspenina J, Koch I, Richter M, Bink K, Kremer M, Specht K, Krugmann J, Quintanilla-Martinez L, Fend F.

Leuk Res. 2008 Jan;32(1):79-88. Epub 2007 Jul 16.


Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.

Chuang SS, Huang WT, Hsieh PP, Tseng HH, Campo E, Colomer D, Ye H, Lu CL, Chang HM, Cho CY, Huang SH, Lu YC, Wu JD.

Pathol Int. 2006 Aug;56(8):440-8.


Correlation of cyclin D1 transcript levels, transcript type and protein expression with proliferation and histology among mantle cell lymphoma.

Shakir R, Ngo N, Naresh KN.

J Clin Pathol. 2008 Aug;61(8):920-7. doi: 10.1136/jcp.2008.057455. Epub 2008 Jun 13.


No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo.

Vogt N, Abramov D, Koch K, Masqué-Soler N, Szczepanowski M, Klapper W.

Leuk Lymphoma. 2015 Jul;56(7):2134-40. doi: 10.3109/10428194.2014.975700. Epub 2014 Nov 14.


Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.

Masamha CP, Albrecht TR, Wagner EJ.

J Hematol Oncol. 2016 Mar 29;9:30. doi: 10.1186/s13045-016-0260-7.


[Detection of cyclin D1 mRNA by reverse transcription-polymerase chain reaction in paraffin-embedded tissues and its diagnostic significance for mantle cell lymphoma].

Shui RH, Wei YK, Sun MH, Wang J, Shi DR, Zhang TM, Jin AP, Zhu XZ.

Zhonghua Bing Li Xue Za Zhi. 2005 Aug;34(8):514-8. Chinese.


The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.

Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Fisher RI, Miller TP, LeBlanc M, Ott G, Kvaloy S, Holte H, Delabie J, Staudt LM.

Cancer Cell. 2003 Feb;3(2):185-97.


Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.

Salaverria I, Zettl A, Beà S, Moreno V, Valls J, Hartmann E, Ott G, Wright G, Lopez-Guillermo A, Chan WC, Weisenburger DD, Gascoyne RD, Grogan TM, Delabie J, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Rosenwald A, Campo E.

J Clin Oncol. 2007 Apr 1;25(10):1216-22. Epub 2007 Feb 12.


Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.

Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI, Grogan TM, Miller TP, Wilson WH, Jaffe ES, Staudt LM.

Blood. 2007 Jun 1;109(11):4599-606. Epub 2007 Feb 13.


Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.

Hui P, Howe JG, Crouch J, Nimmakayalu M, Qumsiyeh MB, Tallini G, Flynn SD, Smith BR.

Leuk Lymphoma. 2003 Aug;44(8):1385-94.


Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma.

Jin L, Tabe Y, Kimura S, Zhou Y, Kuroda J, Asou H, Inaba T, Konopleva M, Andreeff M, Miida T.

Br J Cancer. 2011 Jan 4;104(1):91-100. doi: 10.1038/sj.bjc.6606007. Epub 2010 Dec 7.


In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.

Athanasiou E, Kotoula V, Hytiroglou P, Kouidou S, Kaloutsi V, Papadimitriou CS.

Mod Pathol. 2001 Feb;14(2):62-71.


A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.

Kurita D, Takeuchi K, Kobayashi S, Hojo A, Uchino Y, Sakagami M, Ohtake S, Takahashi H, Miura K, Iriyama N, Sugitani M, Miyoshi H, Hatta Y, Ohshima K, Takei M.

Virchows Arch. 2016 Oct;469(4):471-6. doi: 10.1007/s00428-016-1995-9. Epub 2016 Jul 25.


3'UTR mediated regulation of the cyclin D1 proto-oncogene.

Deshpande A, Pastore A, Deshpande AJ, Zimmermann Y, Hutter G, Weinkauf M, Buske C, Hiddemann W, Dreyling M.

Cell Cycle. 2009 Nov 1;8(21):3592-600. Epub 2009 Nov 3.


The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.

Cao X, Fan L, Fang C, Zhu DX, Dong HJ, Wang DM, Wang YH, Xu W, Li JY.

Med Oncol. 2012 Jun;29(2):1190-6. doi: 10.1007/s12032-011-9937-5. Epub 2011 Apr 9.


Characterization of genetic changes in MCL by interphase FISH on tissue sections.

Sander B, Wallblom A, Ekroth A, Porwit A, Kimby E.

Leuk Lymphoma. 2007 Jul;48(7):1344-52.


Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.

Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, Yamaguchi M, Tamaru J, Uike N, Hashimoto Y, Morishima Y, Suchi T, Seto M, Nakamura S.

Blood. 2000 Apr 1;95(7):2253-61.

Supplemental Content

Support Center